Amarin Corp PLC (AMRN)
0.7963
+0.01
(+0.64%)
USD |
NASDAQ |
Jul 26, 16:00
0.7963
0.00 (0.00%)
After-Hours: 20:00
Amarin Price to Book Value: 0.5993 for July 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| July 25, 2024 | 0.5955 |
| July 24, 2024 | 0.5903 |
| July 23, 2024 | 0.591 |
| July 22, 2024 | 0.5939 |
| July 19, 2024 | 0.5906 |
| July 18, 2024 | 0.5945 |
| July 17, 2024 | 0.587 |
| July 16, 2024 | 0.5946 |
| July 15, 2024 | 0.5652 |
| July 12, 2024 | 0.5876 |
| July 11, 2024 | 0.5613 |
| July 10, 2024 | 0.5708 |
| July 09, 2024 | 0.5268 |
| July 08, 2024 | 0.5566 |
| July 05, 2024 | 0.5543 |
| July 03, 2024 | 0.5166 |
| July 02, 2024 | 0.5306 |
| July 01, 2024 | 0.5163 |
| June 28, 2024 | 0.5178 |
| June 27, 2024 | 0.5275 |
| June 26, 2024 | 0.5255 |
| June 25, 2024 | 0.5481 |
| June 24, 2024 | 0.5336 |
| June 21, 2024 | 0.5194 |
| June 20, 2024 | 0.5351 |
| Date | Value |
|---|---|
| June 18, 2024 | 0.5495 |
| June 17, 2024 | 0.5705 |
| June 14, 2024 | 0.5856 |
| June 13, 2024 | 0.606 |
| June 12, 2024 | 0.6116 |
| June 11, 2024 | 0.5795 |
| June 10, 2024 | 0.4726 |
| June 07, 2024 | 0.5065 |
| June 06, 2024 | 0.5304 |
| June 05, 2024 | 0.5328 |
| June 04, 2024 | 0.5268 |
| June 03, 2024 | 0.6417 |
| May 31, 2024 | 0.651 |
| May 30, 2024 | 0.6324 |
| May 29, 2024 | 0.6322 |
| May 28, 2024 | 0.6323 |
| May 24, 2024 | 0.6378 |
| May 23, 2024 | 0.6354 |
| May 22, 2024 | 0.6561 |
| May 21, 2024 | 0.6748 |
| May 20, 2024 | 0.6622 |
| May 17, 2024 | 0.6548 |
| May 16, 2024 | 0.6867 |
| May 15, 2024 | 0.7044 |
| May 14, 2024 | 0.6847 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4726
Minimum
Jun 10 2024
52.19
Maximum
Jul 31 2019
4.428
Average
2.064
Median
Price to Book Value Benchmarks
| Trinity Biotech PLC | -- |
| Cellectis SA | 2.564 |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals Plc | 1.806 |
| Verona Pharma PLC | 8.195 |
Price to Book Value Related Metrics
| PS Ratio | 1.173 |
| Price to Free Cash Flow | 252.84 |
| Price | 0.7963 |
| Earnings Yield | -16.33% |
| Market Cap | 327.17M |